Health Care: Drugs

Alkermes PLC (ALKS: NASDAQ)

$46.21 0.79 | 1.74%
07/23/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 45.25
52 Week High 54.25
52 Week Low 28.86
Avg. Daily Vol. (Mil) 0.82
Beta (3 year) 1.52
Share Related Items
Mkt Cap (Mil) 6,539.31
Shares Out (Mil) 144.52
Float (Mil) 87.19
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.30
Current Ratio 8.40
LT Debt/ Equity 0.27
Total Debt / Equity 0.27
Valuation Ratios
Price Earnings 371.70
Price/Sales 15.11
Price/Book 4.88
Price/Cash Flow 116.60
Per Share Data
Earnings 0.12
Sales 3.00
Book Value 9.27
Cash Flow 0.39
Business Summary
Alkermes PLC is a biotechnology company. It is engaged in developing, manufacturing and commercializing medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious diseases.
General Information
Connaught House
1 Burlington Road
Dublin, 4
www.alkermes.com
Industry : Drugs
Sector: Health Care
Employees: 1250
CEO: Richard F. Pops
Short Interest
Current Month (Mil) 4.82
Previous Month (Mil) 4.48
Short Interest Ratio (Days) 6.20
Management Effectiveness
Return on Equity n.a.
Return on Assets 0.00
Return on Investments n.a.
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 4.10

Portfolios with ALKS

Latest ALKS Headlines from TheStreet

More Financial News for ALKS

Press Releases for ALKS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter